1983•Annals of Tropical Medicine and ParasitologyRequires access
A comparative trial of praziquantel, metrifonate and niridazole againstSchistosoma haematobium
J. E. McMahon
Open publisher page 20 citations
Abstract
Praziquantel administered in a single oral dose of 30 mg kg-1 to subjects infected with Schistosoma haematobium produced minimal side effects and was more effective than established regimes of niridazole and metrifonate. Praziquantel should prove a major tool in schistosomiasis control programmes.